Personal tools

MCL coexpression mm9:229: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002107!1.49e-14!22;UBERON:0007499!1.49e-14!22;UBERON:0006925!1.49e-14!22;UBERON:0009497!1.49e-14!22;UBERON:0000015!1.49e-14!22;UBERON:0002423!1.49e-14!22;UBERON:0006235!1.49e-14!22;UBERON:0008835!1.49e-14!22;UBERON:0003894!1.49e-14!22;UBERON:0004161!1.49e-14!22;UBERON:0008836!1.49e-14!22;UBERON:0009854!1.00e-13!23;UBERON:0009856!1.00e-13!23;UBERON:0002365!2.84e-12!25;UBERON:0002330!2.84e-12!25;UBERON:0005172!6.39e-08!49;UBERON:0005173!6.39e-08!49;UBERON:0002417!6.39e-08!49;UBERON:0000916!6.39e-08!49;UBERON:0005256!2.38e-07!45
|ontology_enrichment_uberon=UBERON:0002107!1.49e-14!22;UBERON:0007499!1.49e-14!22;UBERON:0006925!1.49e-14!22;UBERON:0009497!1.49e-14!22;UBERON:0000015!1.49e-14!22;UBERON:0002423!1.49e-14!22;UBERON:0006235!1.49e-14!22;UBERON:0008835!1.49e-14!22;UBERON:0003894!1.49e-14!22;UBERON:0004161!1.49e-14!22;UBERON:0008836!1.49e-14!22;UBERON:0009854!1.00e-13!23;UBERON:0009856!1.00e-13!23;UBERON:0002365!2.84e-12!25;UBERON:0002330!2.84e-12!25;UBERON:0005172!6.39e-08!49;UBERON:0005173!6.39e-08!49;UBERON:0002417!6.39e-08!49;UBERON:0000916!6.39e-08!49;UBERON:0005256!2.38e-07!45
|tfbs_overrepresentation_for_novel_motifs=0.0413918,0.0142405,0.136137,1.1916,1.09379,0.477421,0.0999514,0.233506,0.0592285,0.0193351,0.0797769,0.313172,0.0159381,0.344675,0.850466,0,0.219948,1.40558,0.199105,0.0511272,0.257014,0.479715,0.105521,0.295133,0.0359234,0.765668,0.310154,0.520899,0.0183682,0.305597,0.226861,0.792615,0.276494,0.396684,0.0135241,0.0123317,0.00858937,0.308579,0.597103,0.00402253,0.495389,0.0653858,1.13969,0.171902,0.00917849,0.051485,0.168814,0.0754467,2.44156,0.674939,0.208313,0.418967,0.280726,0.401722,0.415953,0.35415,0.227815,0.618102,0.281837,0.108526,0.276833,0.139862,0.691468,0.200931,0.115245,0.227914,0.531135,0.84881,0.273438,0.711943,0.0289067,0.864253,5.2419e-05,1.12847,0.0011271,0.0616852,0.0690293,0.161952,0.264428,2.03877,0.621215,0.231745,0.430279,0.365955,0.350386,7.84242e-05,0.000660881,0.101973,0.171806,1.00305,0.592345,0.354286,0.81417,1.12775,0.00595581,1.72701,0.812838,0.303162,0.504794,0.0712566,0.446256,0.792145,0.387634,0.600658,0.20801,0.0652131,0.24871,0.0737572,0.112458,0.0250628,0.153706,0.389069,0.496004,0.279833,0.598607,0.285849,4.52516e-05,0.0567793,0.220825,0.434443,0.448157,0.549804,0.121031,0.16141,0.647114,0.267084,0.692294,0.296009,0.529818,0.814978,0.374039,0.433678,0.504302,0.116549,0.617878,0.0429794,1.05338,0.505179,0.574183,1.36129,0.972535,0.535229,0.400744,0.810229,0.203754,0.233214,0.170717,1.32235,0.387049,0.302389,0.315022,2.35457e-05,0.402997,0.027977,0.116068,0.470737,1.34676,0.071462,1.00965,0.0439242,0.582585,0.349717,0.267404,0.0385939,0.583725,0.361253,0.0435759,0.642999,0.0170506
}}
}}

Revision as of 18:01, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:109958858..109958900,-p@chr11:109958858..109958900
-
Mm9::chr11:121349277..121349318,+p5@Tbcd
Mm9::chr14:46840780..46840799,+p@chr14:46840780..46840799
+
Mm9::chr14:46840814..46840827,+p@chr14:46840814..46840827
+
Mm9::chr14:60796888..60796921,-p@chr14:60796888..60796921
-
Mm9::chr14:66759756..66759799,+p1@Chrna2
Mm9::chr15:10153615..10153627,+p10@Prlr
Mm9::chr16:26358205..26358227,-p@chr16:26358205..26358227
-
Mm9::chr16:32010196..32010224,-p@chr16:32010196..32010224
-
Mm9::chr17:28578319..28578332,-p@chr17:28578319..28578332
-
Mm9::chr17:8465391..8465394,-p@chr17:8465391..8465394
-
Mm9::chr19:12699915..12699916,+p@chr19:12699915..12699916
+
Mm9::chr19:37338550..37338603,-p1@4931408D14Rik
Mm9::chr19:38236670..38236680,+p@chr19:38236670..38236680
+
Mm9::chr19:38236709..38236722,+p@chr19:38236709..38236722
+
Mm9::chr1:138558723..138558736,+p@chr1:138558723..138558736
+
Mm9::chr1:72816185..72816201,-p@chr1:72816185..72816201
-
Mm9::chr1:74061226..74061268,-p@chr1:74061226..74061268
-
Mm9::chr1:74292560..74292563,+p@chr1:74292560..74292563
+
Mm9::chr2:131929154..131929182,-p@chr2:131929154..131929182
-
Mm9::chr2:131929190..131929201,-p@chr2:131929190..131929201
-
Mm9::chr2:165225898..165225910,-p1@4833422F24Rik
Mm9::chr2:79209227..79209247,-p@chr2:79209227..79209247
-
Mm9::chr3:10014510..10014513,+p@chr3:10014510..10014513
+
Mm9::chr6:108422530..108422543,-p@chr6:108422530..108422543
-
Mm9::chr6:90569345..90569357,+p10@Slc41a3
Mm9::chr6:90569359..90569376,+p5@Slc41a3
Mm9::chr7:149847748..149847762,-p10@Igf2
Mm9::chr7:149847763..149847785,-p4@Igf2
Mm9::chr8:10865998..10866082,-p@chr8:10865998..10866082
-
Mm9::chr8:121948230..121948243,-p@chr8:121948230..121948243
-
Mm9::chr8:121948244..121948262,-p@chr8:121948244..121948262
-
Mm9::chr8:121948361..121948381,+p@chr8:121948361..121948381
+
Mm9::chr9:110246575..110246581,+p10@Scap
Mm9::chr9:110895276..110895298,+p@chr9:110895276..110895298
+
Mm9::chr9:110895319..110895324,+p@chr9:110895319..110895324
+
Mm9::chr9:70782615..70782654,-p2@Lipc


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
liver1.49e-1422
epithelial sac1.49e-1422
digestive gland1.49e-1422
epithelium of foregut-midgut junction1.49e-1422
anatomical boundary1.49e-1422
hepatobiliary system1.49e-1422
foregut-midgut junction1.49e-1422
hepatic diverticulum1.49e-1422
liver primordium1.49e-1422
septum transversum1.49e-1422
liver bud1.49e-1422
digestive tract diverticulum1.00e-1323
sac1.00e-1323
exocrine gland2.84e-1225
exocrine system2.84e-1225
abdomen element6.39e-0849
abdominal segment element6.39e-0849
abdominal segment of trunk6.39e-0849
abdomen6.39e-0849
trunk mesenchyme2.38e-0745


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}